ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Hematology Oncology

Top Hematology Oncology Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PIYAPONG VONGKOVIT MD

Hematology Oncology

554

$708K

122
114 are 65+

19%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 19%

$1278
Average prescription price

Avg: $386

HARMINDER SETHI MD

Hematology Oncology

596

$486K

71
55 are 65+

27%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$816
Average prescription price

Avg: $386

BRUCE KRESSEL M.D.

Hematology Oncology

517

$468K

96
91 are 65+

14%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 19%

$905
Average prescription price

Avg: $386

THOMAS SACKS M.D.

Hematology Oncology

1,868

$225K

143
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 19%

$121
Average prescription price

Avg: $386

PATRICIA ONEAL MD

Hematology Oncology

485

$408K

57
15 are 65+

65%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 19%

$842
Average prescription price

Avg: $386

CLAUDINE ISAACS

Hematology Oncology

101

$16.1K

22
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 19%

$159
Average prescription price

Avg: $386

PIA HERBOLSHEIMER MD

Hematology Oncology

431

$61.6K

46
29 are 65+

28%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$143
Average prescription price

Avg: $386

IMAD TABBARA M.D.

Hematology Oncology

489

$307K

80
60 are 65+

23%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 19%

$627
Average prescription price

Avg: $386

ADRIANA MEDINA M.D.

Hematology Oncology

804

$65.2K

108
63 are 65+

17%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$81
Average prescription price

Avg: $386

KAREN SMITH MD

Hematology Oncology

301

$61.5K

56
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 19%

$204
Average prescription price

Avg: $386

REBECCA KALTMAN MD

Hematology Oncology

144

$12.5K

38
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 19%

$87
Average prescription price

Avg: $386

ROBERT WARREN

Hematology Oncology

250

$25K

53
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 19%

$100
Average prescription price

Avg: $386

JOHN MCKNIGHT M.D.

Hematology Oncology

416

$94.8K

66
55 are 65+

20%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 19%

$228
Average prescription price

Avg: $386

ALLAN LOUIE CRUZ M.D.

Hematology Oncology

792

$48.8K

128
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 15%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 19%

$62
Average prescription price

Avg: $386

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank